See a Demo

Transparent Thinking Blog

TrialAssure cubes divider
National Registry for Clinical Studies (RNEC) in Portugal trialassure

REGISTRY SNAPSHOT: National Registry for Clinical Studies (RNEC) in Portugal

by Staff Writer | July 2019

Posted in Snapshots
Read More

This week in transparency news: June 29 – July 12, 2019

by Staff Writer | July 2019

Posted in Blog
Read More
Philippine Health Research Registry (PHRR) trialassure

REGISTRY SNAPSHOT: Philippine Health Research Registry (PHRR)

by Staff Writer | July 2019

Posted in Snapshots
Read More
German Clinical Trials Register (DRKS) trialassure

REGISTRY SNAPSHOT: German Clinical Trials Register (DRKS)

by Staff Writer | July 2019

Posted in Snapshots
Read More

This week in transparency news: June 22 – June 28, 2019

by Staff Writer | June 2019

Posted in Blog
Read More
The FDA issued a draft guidance in September 2018 to detail the regulatory body’s thinking on monetary penalties of up to $10,000 per day for failing to register a clinical trial, patterns of previous noncompliance, and/or submitting misleading or false information to ClinicalTrials.gov. While the FDA has not previously begun issuing fines to pharmaceutical companies, this guidance brings that reality one step closer. Zach Weingarden, Product Solutions Manager, TrialAssure, helps clarify some common questions on this draft guidance that sponsors and other partners have been asking. Zach Weingarden, Product Solutions Manager, TrialAssure

How TrialAssure Gathers Client Feedback to Build Stronger Clinical Trial Transparency Software

by Zach Weingarden | June 2019

Posted in Blog
Read More
Peruvian Clinical Trials Registry (REPEC) peru trialassure

REGISTRY SNAPSHOT: The Peruvian Clinical Trials Registry (REPEC)

by Staff Writer | June 2019

Posted in Snapshots
Read More
Policy 0070 submissions pending suspension in Europe – DIA Communities Due to EMA’s relocation from London to Amsterdam, the “launch of new procedures (related to clinical data publication under Policy 0070) will be temporarily suspended already as of 1 August 2018,” according to an email shared by Melanie Carr, Head of Stakeholders and Communication Division and Head of Corporate Stakeholders Department ad interim, European Medicines Agency (EMA). It is noted that all redaction proposal packages submitted after July 31st will be temporarily suspended. A press release with full details is said to be released next week.

This week in transparency news: June 15 – June 21, 2019

by Staff Writer | June 2019

Posted in Blog
Read More
Pan African Clinical Trials Registry (PACTR) south africa trialassure

REGISTRY SNAPSHOT: Pan African Clinical Trials Registry (PACTR)

by Staff Writer | June 2019

Posted in Snapshots
Read More
The U.S. Senate had voted in favor of an opioid bill that expands Open Payments to include payments made to Nurse Practitioners, Physician Assistants, Nurse Midwifes, Nurse Anesthetists, and Clinical Nurse Specialists, in addition to current physician reporting requirements. This will go into effect beginning January 1, 2022. Inconsistent Clinical Trial Disclosure and Lack of Compliance Across Big Pharma

This week in transparency news: June 8 – June 14, 2019

by Staff Writer | June 2019

Posted in Blog
Read More
Get in Touch

Looking to streamline your clinical trial disclosure and transparency efforts?

TrialAssure is ready to help your organization embark on a Transparency Transformation!

To learn more about the TrialAssure Transparency Suite, specific products, or our company, contact us below.

Yes, please send me more information about TrialAssure.

  • *